![]() |
市场调查报告书
商品编码
1955065
全球便携式超音波市场:市场规模、占有率、成长率、行业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034 年)Portable Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球便携式超音波市场规模为 33.7 亿美元,预计 2026 年将成长至 37.7 亿美元。预计到 2034 年,该市场规模将达到 90.7 亿美元,在预测期(2026-2034 年)内复合年增长率 (CAGR) 为 11.58%。
北美地区引领全球市场,在 2025 年占 36.04% 的市场占有率,这得益于其强大的医疗保健基础设施和先进诊断成像技术的快速普及。
便携式超音波系统是一种紧凑型行动影像设备,用于在多个专科领域进行即时诊断评估,包括:心臟病学、产科、骨科和急诊医学。门诊和床边应用的增加显着推动了市场成长。
新冠疫情的影响
由于择期手术取消和就诊量下降,新冠疫情对便携式超音波市场造成了负面影响。由于封锁措施和医疗资源集中用于应对疫情,常规诊断影像受到限制。供应链中断和生产放缓也影响了销售。
然而,由于超音波设备偶尔用于诊断伴有肺部和心臟併发症的新冠患者,需求出现了有限的增长。疫情后的復苏恢復了成长势头,预计到2034年将保持强劲的复合年增长率。
市场驱动因素
急诊医学领域应用增加
便携式超音波系统在急诊室的广泛应用是市场驱动因素之一。这些设备可提供快速、即时的成像,并支援即时的临床决策。其非侵入性和快速部署的特性使其成为创伤护理和急救医疗环境中不可或缺的工具。
产品发布增加
持续的技术创新和新产品的推出正在推动进一步成长。各公司正在整合先进的成像功能、无线功能和人工智慧驱动的诊断工具。例如,手持式和无线系统的推出正在将其应用范围从传统的医院扩展到门诊和远距医疗环境。
市场限制因子
有限的报销政策和监管问题仍然是主要挑战。在某些地区,超音波检查只有在符合严格标准的情况下才能获得报销。此外,监管机构对潜在的不必要影像和误诊的审查可能会阻碍其普及。这些因素可能会在预测期内抑製成长。
最新趋势
人工智慧 (AI) 的整合
人工智慧 (AI) 的整合是重要的市场趋势。 AI 驱动的超音波系统能够提高影像解读的准确性、实现自动测量并增强诊断准确性。基于深度学习的量化工具在诊断影像软体中的整合正在不断增加。
此外,手持式超音波设备的广泛应用正在扩大初级保健、家庭医疗保健和远距医疗中诊断影像的覆盖范围,从而支持市场的长期成长。
依类型
市场依类型分为内建控制台型和触控萤幕型。
依最终使用者划分
依最终用户划分,市场分为医院和诊所。
北美
北美市场规模位居榜首,2025年市场规模达12.1亿美元,2026年达13.4亿美元。光是美国市场预计在2026年就将达到13.1亿美元,主要得益于高癌症发生率和对急诊影像诊断的强劲需求。
欧洲
欧洲市场规模位居第二,这主要得益于医疗保健支出的成长和新产品的推出。预计2026年,英国市场规模将达1.9亿美元,德国市场规模将达2.7亿美元。 亚太地区 预计到2034年,亚太地区的复合年增长率将最高。到2026年,在医疗保健投资不断增长和庞大患者群体的推动下,预计日本市场规模将达到5.7亿美元,中国将达到4.5亿美元,印度将达到9,000万美元。
拉丁美洲、中东和非洲
截至2025年,这些地区的市场占有率相对较小,但由于基础设施的改善以及人们对便携式医疗影像益处的认识不断提高,预计未来将实现强劲增长。
The global portable ultrasound market was valued at USD 3.37 billion in 2025 and is projected to grow to USD 3.77 billion in 2026. The market is forecasted to reach USD 9.07 billion by 2034, exhibiting a CAGR of 11.58% during the forecast period (2026-2034).
North America dominated the global market with a 36.04% market share in 2025, driven by strong healthcare infrastructure and rapid adoption of advanced diagnostic imaging technologies.
Portable ultrasound systems are compact, mobile imaging devices used for real-time diagnostic assessment across multiple specialties, including cardiology, obstetrics, orthopedics, and emergency medicine. Their increasing use in outpatient settings and point-of-care applications is significantly boosting market growth.
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the portable ultrasound market due to the cancellation of elective procedures and reduced hospital visits. Lockdowns and healthcare resource diversion toward pandemic management limited routine diagnostic imaging. Supply chain disruptions and manufacturing slowdowns also affected sales.
However, ultrasound devices were occasionally used in COVID-19 diagnosis for lung and cardiac complications, creating limited positive demand. Post-pandemic recovery has restored growth momentum, contributing to the strong CAGR projected through 2034.
Market Drivers
Rising Adoption in Emergency Care
One of the major drivers of market growth is the extensive use of portable ultrasound systems in emergency departments. These devices provide rapid, real-time imaging and support immediate clinical decisions. Their non-invasive nature and quick deployment make them essential tools in trauma care and critical settings.
Increasing Product Launches
Continuous innovation and new product introductions are further fueling growth. Companies are integrating advanced imaging capabilities, wireless functionality, and AI-powered diagnostic tools. For example, the introduction of handheld and wireless systems has expanded usage beyond traditional hospital environments into ambulatory and remote care settings.
Market Restraints
Limited reimbursement policies and regulatory concerns remain key challenges. In some regions, ultrasound procedures qualify for reimbursement only under strict criteria. Additionally, regulatory scrutiny over unnecessary imaging and potential misdiagnosis may limit broader adoption. These factors could restrain growth during the forecast period.
Latest Trends
Integration of Artificial Intelligence
The incorporation of artificial intelligence (AI) is a prominent market trend. AI-enabled ultrasound systems enhance image interpretation, automate measurements, and improve diagnostic accuracy. Deep learning-based quantification tools are increasingly being integrated into imaging software.
Furthermore, the rising popularity of handheld ultrasound devices is expanding access to imaging across primary care, home healthcare, and telemedicine, thereby supporting long-term market expansion.
By Type
The market is segmented into built-in console and touchscreen systems.
By End User
Based on end users, the market is segmented into hospitals and clinics.
North America
North America led the market with a valuation of USD 1.21 billion in 2025 and USD 1.34 billion in 2026. The U.S. market alone is projected to reach USD 1.31 billion in 2026, supported by high cancer incidence rates and strong demand for emergency imaging.
Europe
Europe is the second-largest market, driven by strong healthcare spending and new product launches. The U.K. market is projected to reach USD 0.19 billion in 2026, while Germany is expected to reach USD 0.27 billion in 2026.
Asia Pacific
Asia Pacific is anticipated to record the highest CAGR through 2034. By 2026, Japan is projected to reach USD 0.57 billion, China USD 0.45 billion, and India USD 0.09 billion, supported by growing healthcare investments and a large patient base.
Latin America & Middle East & Africa
These regions held comparatively smaller shares in 2025 but are expected to witness strong growth due to infrastructure improvements and rising awareness of portable imaging benefits.
Competitive Landscape
The market features strong competition among global and regional players. Leading companies include GE Healthcare and Koninklijke Philips N.V., which hold significant shares due to robust product portfolios and continuous R&D investments. Other prominent players include Fujifilm Sonosite, Mindray, CHISON, Hitachi Ltd., Butterfly Network, and EDAN Instruments.
Recent developments include the launch of GE Healthcare's Vscan Air wireless ultrasound system and Philips' FDA-approved ultrasound portfolio for COVID-19-related complications management.
Conclusion
The global portable ultrasound market is poised for substantial growth from USD 3.37 billion in 2025 to USD 9.07 billion by 2034, driven by technological advancements, increasing outpatient care, and rising demand for point-of-care diagnostics. While reimbursement challenges and regulatory concerns may restrain growth, strong innovation, AI integration, and expanding adoption in emergency and specialty clinics will sustain long-term expansion. North America remains dominant, while Asia Pacific is expected to emerge as the fastest-growing region during the forecast period.
Segmentation By Type
By End User
By Geography